This research aims to determine the effectiveness of statin therapy in preventing coronary events based on C-reactive protein levels.
Measurement of C-reactive protein levels in subjects
Targeted administration of statin therapy based on C-reactive protein results
Focus on primary prevention in patients with low lipid levels
Elevated C-reactive protein levels indicate potential effectiveness of statin therapy for preventing acute coronary events.
Subjects with low lipid levels but high C-reactive protein experienced better outcomes with statin therapy.
Resumen
Statin therapy may be effective in the primary prevention of coronary events among subjects with relatively low lipid levels but with elevated levels of C-reactive protein.